Myelin basis protein and myelin oligodendrocyte glycoprotein T-cell repertoire in childhood and juvenile multiple sclerosis

Multiple Sclerosis

Volumn 12, Issue 4, 2006, Pages 412-420

  Correale, Jorge ^a   Tenembaum, Silvia N ^b  

^a Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

^b HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Childhood; MBP; MOG; Multiple sclerosis; T cells

Indexed keywords

BETA1A INTERFERON; EPITOPE; GAMMA INTERFERON; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE DERIVATIVE; MYELIN ASSOCIATED GLYCOPROTEIN; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; PEPTIDE FRAGMENT;

ADOLESCENT; ARTICLE; CELL ISOLATION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG DOSE REGIMEN; EXON; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; ONSET AGE; PERIPHERAL LYMPHOCYTE; T LYMPHOCYTE; CELL LINE; COHORT ANALYSIS; CYTOLOGY; EPITOPE MAPPING; IMMUNOLOGY; PRESCHOOL CHILD; SECRETION;

ADOLESCENT; AGE OF ONSET; CELL LINE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; INTERFERON TYPE II; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MYELIN BASIC PROTEINS; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDE FRAGMENTS; T-LYMPHOCYTES;

EID: 33746519899     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135248506ms1282oa     Document Type: Article

References (34)

1. Martin R, McFarland HF. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 1995; 32: 121-82.
2. Stinissen P, Raus J, Zhang J. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit Rev Immunol 1997; 17: 33-75.
3. Voskuhl RR, McFarlin DE, Tranquill LR, Deibler G, Stone R, Maloni H et al. A novel candidate autoantigen in a multiplex family with multiple sclerosis: prevalence of T-lymphocytes specific for an MBP epitope unique to myelination. J Neuroimmunol 1993; 46: 137-44.
4. Voskuhl RR, Robinson ED, Segal BM, Tranquill L, Camphausen K, Albert PS et al. HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis. J Immunol 1994; 153: 4834-44.
5. Roth H, Kronquist KE, Kerlero de Rosbo N, Crandall BF, Campagnoni AT. Evidence for the expression of four myelin basic protein variants in the developing human spinal cord through cDNA cloning. J Neurosci Res 1987; 17: 321-28.
6. Kristensson K, Holmes KV, Duchala CS, Zeller NK, Lazzarini RA, Dubois-Dalcq M. Increased levels of myelin basic protein transcripts in virus-induced demyelination. Nature 1986; 322: 544-47.
7. Linington C, Bradl M, Lassmann H, Brunner C, Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against myelin/oligodendrocyte glycoprotein. Am J Pathol 1988; 130: 443-54.
8. Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, Zhang Y et al. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 1993; 23: 1364-72.
9. Genain CP, Nguyen MH, Letvin NL, Pearl R, Davis RL, Adelman M et al. Antibody facilitation of multiple sclerosis-like lesions in a non-human primate. J Clin Invest 1995; 96: 2966-74.
10. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
11. Correale J, Bassani Molinas M de los M. Time course of T-cell responses to MOG and MBP in patients with clinically isolated syndromes. J Neuroimmunol 2003; 136: 162-71.
12. Correale J, Fiol M. Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology 2004; 63: 2363-70.
13. Wekerle H, Kojiman K, Lannes-Vieira J, Lassmann H, Linington C. Animal models. Ann Neurol 1994; 36: S47-53.
14. Hanefeld FA. Characteristics of childhood multiple sclerosis. Int MS J 1995; 1: 91-97.
15. Rust R, Menkes JH. Autoimmune and postinfectious diseases. In Menkes JH, Sarnat HB eds. Child neurology, sixth edition. Lippincott Williams and Wilkins, 2002: 627-91.
16. Duquette P, Murray TJ, Pleines J, Ebers; GC, Sadovnick D, Weldon P et al. Multiple sclerosis in childhood: clinical profile in 125 patients. J Pediatr 1987; 111: 359-63.
17. Matthews B. Symptoms and signs of multiple sclerosis. In Compston A, Ebers G, Lassmann H, McDonald I, Matthews B, Wekerle H eds. McAlpine's multiple sclerosis, third edition. Churchill-Livingstone, 1998: 145-90.
18. Ruggieri M, Polizzi A, Pavone L, Grimaldi LM. Multiple sclerosis in children under 6 years of age. Neurology 1999; 53: 478-84.
19. Gadoth N. Multiple sclerosis in children. Brain Dev 2003; 25: 229-32.
20. Banwell BL. Pediatric multiple sclerosis. Curr Neurol Neurosurg Rep 2004; 31: 201-26.
21. Sevon M, Sumelahti ML, Tienari P Haltia M, Iivanainen M. Multiple sclerosis in childhood and its prognosis. Int MS J 2001; 8: 29-33.
22. Hahn CD, Shroff MM, Blaser SI, Banwell BL. MRI criteria for multiple sclerosis: evaluation in a pediatric cohort. Neurology 2004; 62: 806-808.
23. Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi Ab/H mice. J Immunol 1994; 153: 4349-56.
24. Kerlero de Rosbo N, Mendel I, Ben-Nun A. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glyco-protein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur J Immunol 1995; 25: 985-93.
25. Johns T, Kerlero de Rosbo N, Menon KK, Abo S, Gonzales MF, Bernard CC et al. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol 1995; 154: 5536-41.
26. b mice. Fine specificity and T cell receptor VΒ expression of encephalitogenic T cells. Eur J Immunol 1995; 25: 1951-59.
27. Kerlero de Rosbo N, Brok HPM, Bauer J, Kaye JF,'t Hart BA, Ben-Nun A. Rhesus monkeys are highly susceptible to experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein: characterization of immunodominant T- and B-cell epitopes. J Neuroimmunol 2000; 110: 83-96.
28. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990; 346: 183-87.
29. Vergelli M, Kalbus M, Rojo SC, Hemmer B, Kalbacher H, Tranquill L et al. T cell response to myelin basic protein in the context of the multiple sclerosis associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells. J Neuroimmunol 1997; 77: 195-203.
30. Segal BM, Raine CS, McFarlin DE, Voskuhl RR, McFarland HF. Experimental allergic encephalomyelitis induced by the peptide encoded by exon 2 of the MBP gene, a peptide implicated in remyelination. J Neuroimmunol 1994; 51: 7-19.
31. Bielekova B, Sung MH, Kadom N, Simon R, McFarland H, Martin R. Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis. J Immunol 2004; 172: 3893-904.
32. Tuohy VK, Yu M, Yin L, Kawczak JA, Johnson JM, Mathisen PM et al, The epitope spreading cascade during progression of experimental allergic encephalomyelitis and multiple sclerosis. Immunol Rev 1998; 164: 93-100.
33. Tan LJ, Kennedy MK, Dal Canto MC, Miller SD. Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance. J Immunol 1991; 147: 1797-802.
34. Elliot EA, McFarland HJ, Nye SH, Cofiell R, Wilson TM, Wilkins JA et al. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J Clin Invest 1996; 98: 1602-12.